Get the latest updates and exclusive offers directly to your inbox
Barcelona Science Park
Carrer de Baldiri Reixac 10
+34 93 403 70 77
Ensure the safety of your new molecule!
Our new application notes on CacoReady plates will show you how to accurately predict and stratify intestinal toxicity using cutting-edge methods like TEER and LY paracellular flux.
Get for free the latest protocol for acute toxicity assessment.
PreadyPort WT 24w
PreadyPort WT 96w
PreadyPort MDR1 24w
PreadyPort MDR1 96w
PreadyPort BCRP 24w
PreadyPort BCRP 96w
Our latest news
ReadyCell is a biotechnological company focused on providing superior cell-based in vitro plates for the ADME-Tox market segment. Our innovative products facilitate and streamline drug discovery and medical research studies thanks to a revolutionary and patented...
The article highlights the discovery of a series of azetidine derivatives, known as BGAz compounds, that exhibit potent bactericidal activity against both drug-sensitive Mycobacterium tuberculosis and multidrug-resistant TB strains.
In honor of the International Day of Women and Girls in Science, we present a series of videos featuring insights from our team members that explore the diverse experiences and perspectives of the talented women at ReadyCell.
In a recent study published in the Future Pharmacology Journal, researchers from prestigious French companies examined the impact of four polyols on the permeability of seven active pharmaceutical ingredients (APIs).
To convey our spirit, we share a Christmas card, proudly supported by ASHOFI, dedicated to aiding individuals affected by fibromyalgia.
3DLIVER: Celebrating one year of progress in the project for advanced drug toxicity testing and discovery
The main aim of the 3DLIVER project is the generation of innovative human liver-derived 3D in vitro models as innovative ready-to-use kits for drug testing models, using human liver cells and extracellular matrix (ECM), to generate more reliable in vitro drug testing devices.
Evaluating in vitro permeability with CacoReady plates was central to the study design. By quantifying the permeability of the synthesized compounds within Caco-2 cells, researchers could identify and select which compounds were best in terms of cellular adsorption.
ReadyCell is pleased to participate in the XV meeting of the Spanish Drug Discovery Network (SDDN) at the Parc de Recerca Biomèdica de Barcelona (PRBB) on November 20th and 21st, 2023.
The meeting focused on exploring the current market dynamics and emerging trends in the field of cell culture technology and drug discovery. Both companies, ReadyCell and OYC, are committed to providing their customers with top-tier products and services.